Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 7, 2003, Pages 543-547

  Weiss, Brian ^a   Vora, Amish ^a   Huberty, John ^b   Hawkins, Randall A ^b   Matthay, Katherine K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

131I MIBG; Acute myelogenous leukemia; Myelodysplasia; Neuroblastoma; Secondary leukemia

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; BUTHIONINE SULFOXIMINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FENRETINIDE; ISOTRETINOIN; MELPHALAN; TOPOTECAN; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CHILD; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 7; CYTOGENETICS; FEMALE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUROBLASTOMA; PRIORITY JOURNAL; SECOND CANCER;

3-IODOBENZYLGUANIDINE; BONE MARROW; CHILD; CHROMOSOME ABERRATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUKEMIA, RADIATION-INDUCED; MALE; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; RADIOPHARMACEUTICALS; RECURRENCE; TIME FACTORS;

EID: 0038649080     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200307000-00009     Document Type: Article

References (20)

1. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med. 1999;341(16):1165-1173.
2. Klingebiel T, Berthold F, Treuner J, et al. Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial. Med Pediatr Oncol. 1991;19:84-88.
3. 131Imetaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol. 1998;16:229-236.
4. De Kraker J, Hoefnagel CA, Caron H, et al. First-line targeted radiotherapy. a new concept in the treatment of advanced stage neuroblastoma. Eur J Cancer. 1995;31A:600-602.
5. Kushner BH, Cheung NK, Kramer K, et al. Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. J Clin Oncol. 1998;16:3880-3889.
6. Schiavetti A, Varrasso G, Maurizi P, et al. Two secondary leukemias among 15 children given oral etoposide. Med Pediatr Oncol. 2001;37:148-149.
7. 131I-metaiodobenzylguanidine. Cancer. 2003;97:1332-1338.
8. Matthay KK, Panina C, Huberty J, et al. Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG. J Nucl Med. 2001;42:1713-1721.
9. Laurenti L, Salutari P, Sica S, et al. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders. Ann Hematol. 1998;76:271-272.
10. Mukherjee JJ, Kaltsas GA, Islam N, et al. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I)-meta-iodobenzylguanidine. Clin Endocrinol (Oxf). 2001;55:47-60.
11. 131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest. 1997;20:648-658.
12. Dottorini ME, Lomuscio G, Mazzucchelli L, et al. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med. 1995;36:21-27.
13. Hall P, Boice JD Jr, Berg G, et al. Leukaemia incidence after iodine-131 exposure. Lancet. 1992;340:1-4.
14. Rowley JD, Golomb HM, Vardiman J. Acute leukemia after treatment of lymphoma. N Engl J Med. 1977;297:1013.
15. Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986;4:325-345.
16. Smith MA, Rubinstein L, Ungerleider RS. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks. Med Pediatr Oncol. 1994;23:86-98.
17. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629.
18. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996;334:745-751.
19. Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am. 1993;7:401-415.
20. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996;14:2818-2825.